Marina Sánchez‐Frías

510 total citations
25 papers, 259 citations indexed

About

Marina Sánchez‐Frías is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Marina Sánchez‐Frías has authored 25 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Marina Sánchez‐Frías's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Marina Sánchez‐Frías is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Marina Sánchez‐Frías collaborates with scholars based in Spain, United States and France. Marina Sánchez‐Frías's co-authors include Manuel Rodríguez‐Perálvarez, Manuel de la Mata, Rubén Ciria, Raúl M. Luque, Manuel D. Gahete, Gustavo Ferrín, Víctor Amado, Mercedes del Río-Moreno, Justo P. Castaño and Emilia Alors‐Pérez and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Marina Sánchez‐Frías

22 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Sánchez‐Frías Spain 10 148 69 53 48 42 25 259
Yichuan Yuan China 8 126 0.9× 102 1.5× 54 1.0× 93 1.9× 68 1.6× 12 270
Mykola Onyshchenko United States 8 191 1.3× 43 0.6× 105 2.0× 64 1.3× 58 1.4× 20 360
Xinliang Ming China 9 151 1.0× 129 1.9× 60 1.1× 55 1.1× 52 1.2× 12 286
Arianna Lanzi Italy 6 82 0.6× 41 0.6× 82 1.5× 81 1.7× 38 0.9× 11 208
Wen‐Bin Ding China 6 75 0.5× 51 0.7× 77 1.5× 67 1.4× 49 1.2× 11 199
Shaohan Wu China 10 190 1.3× 109 1.6× 29 0.5× 30 0.6× 99 2.4× 20 320
Xinbei Zhou China 6 157 1.1× 152 2.2× 69 1.3× 44 0.9× 14 0.3× 14 276
Mina Farag Canada 9 188 1.3× 103 1.5× 99 1.9× 67 1.4× 38 0.9× 23 339
Ningyuan Wen China 7 71 0.5× 66 1.0× 50 0.9× 110 2.3× 62 1.5× 22 241
Muqddas Tariq Pakistan 7 90 0.6× 27 0.4× 52 1.0× 52 1.1× 73 1.7× 11 242

Countries citing papers authored by Marina Sánchez‐Frías

Since Specialization
Citations

This map shows the geographic impact of Marina Sánchez‐Frías's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Sánchez‐Frías with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Sánchez‐Frías more than expected).

Fields of papers citing papers by Marina Sánchez‐Frías

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Sánchez‐Frías. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Sánchez‐Frías. The network helps show where Marina Sánchez‐Frías may publish in the future.

Co-authorship network of co-authors of Marina Sánchez‐Frías

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Sánchez‐Frías. A scholar is included among the top collaborators of Marina Sánchez‐Frías based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Sánchez‐Frías. Marina Sánchez‐Frías is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamora, Javier, Pilar Barrera, J.L. Montero, et al.. (2025). Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 139–139. 1 indexed citations
2.
Zamora, Javier, J.L. Montero, Marina Sánchez‐Frías, et al.. (2024). Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation. Clinical Transplantation. 38(7). e15405–e15405. 1 indexed citations
3.
Alors‐Pérez, Emilia, Marina Sánchez‐Frías, Andrea Mafficini, et al.. (2024). The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. Cancer Gene Therapy. 31(11). 1646–1657. 2 indexed citations
4.
Ferrer, Alicia Dean, et al.. (2024). Surgical Navigation and CAD-CAM-Designed PEEK Prosthesis for the Surgical Treatment of Facial Intraosseous Vascular Anomalies. Journal of Clinical Medicine. 13(16). 4602–4602. 1 indexed citations
5.
Alors‐Pérez, Emilia, Juan M. Jiménez‐Vacas, Andrea Mafficini, et al.. (2024). Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. Molecular Oncology. 18(10). 2524–2540. 2 indexed citations
6.
Zamora, Javier, Pilar Barrera, Marina Sánchez‐Frías, et al.. (2023). Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. International Journal of Molecular Sciences. 24(3). 2558–2558. 5 indexed citations
7.
Alors‐Pérez, Emilia, Sergio Pedraza‐Arévalo, Antonio Agraz-Doblás, et al.. (2023). Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. Molecular Therapy — Nucleic Acids. 35(1). 102090–102090. 3 indexed citations
8.
López-Cánovas, Juan L, Mercedes del Río-Moreno, Antonio C. Fuentes-Fayos, et al.. (2023). PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing. Experimental & Molecular Medicine. 55(1). 132–142. 15 indexed citations
9.
Alors‐Pérez, Emilia, Saioa Goñi, José C. Reyes, et al.. (2021). Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. Frontiers in Medicine. 8. 720128–720128.
10.
Zamora, Javier, Víctor Amado, Marina Sánchez‐Frías, et al.. (2021). Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences. 22(23). 13073–13073. 23 indexed citations
11.
Amado, Víctor, Javier Zamora, Marina Sánchez‐Frías, et al.. (2021). Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers. 13(10). 2476–2476. 22 indexed citations
12.
13.
Sánchez‐Frías, Marina, et al.. (2021). PTHrP-induced hypercalcemia in paragangliomas: Tumor dedifferentiation as sign of bad prognosis. Endocrinología Diabetes y Nutrición. 69(1). 73–75. 1 indexed citations
14.
López-Cánovas, Juan L, Mercedes del Río-Moreno, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Letters. 496. 72–83. 53 indexed citations
15.
Ferrín, Gustavo, Manuel Rodríguez‐Perálvarez, Marina Sánchez‐Frías, et al.. (2019). mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence. International Journal of Molecular Sciences. 20(2). 336–336. 13 indexed citations
16.
Río-Moreno, Mercedes del, Emilia Alors‐Pérez, Gustavo Ferrín, et al.. (2019). Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 104(8). 3389–3402. 58 indexed citations
17.
Rodríguez‐Perálvarez, Manuel, et al.. (2017). Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact. PLoS ONE. 12(4). e0175010–e0175010. 11 indexed citations
18.
Sánchez‐Frías, Marina, et al.. (2016). Teratoma quístico maduro benigno parotídeo: una entidad extremadamente rara. Revista Española de Cirugía Oral y Maxilofacial. 39(2). 119–121.
19.
Rodríguez‐Perálvarez, Manuel, Pilar Barrera, Gustavo Ferrín, et al.. (2015). Everolimus is safe within the first month after liver transplantation. Transplant Immunology. 33(2). 146–151. 9 indexed citations
20.
Salido‐Vallejo, Rafael, María José Linares-Sicilia, Gloria Garnacho‐Saucedo, et al.. (2012). Subcutaneous phaeohyphomycosis due to Alternaria infectoria in a renal transplant patient: Surgical treatment with no long-term relapse. Revista Iberoamericana de Micología. 31(2). 149–151. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yichuan Yuan Breakdown of academic impact, for papers by Mykola Onyshchenko Breakdown of academic impact, for papers by Xinliang Ming Breakdown of academic impact, for papers by Arianna Lanzi Breakdown of academic impact, for papers by Wen‐Bin Ding Breakdown of academic impact, for papers by Shaohan Wu Breakdown of academic impact, for papers by Xinbei Zhou Breakdown of academic impact, for papers by Mina Farag Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Muqddas Tariq
Rankless by CCL
2026